Advanced search
Publication Cover
Acta Oncologica Volume 53, 2014 - Issue 9
Journal homepage
2,530
Views
49
CrossRef citations to date
0
Altmetric
Sarcoma

Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study

Javier Martin-BrotoSarcoma and Melanoma Units, Son Espases Hospital, Palma de Mallorca, SpainCorrespondence[email protected]
,
Charles S. CleelandDepartment of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Paul A. GlareDepartment of Medicine, Pain and Palliative Care Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
,
Jacob EngellauDepartment of Oncology, Lund University Hospital, Lund, Sweden
,
Keith M. SkubitzHematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA
,
Ronald H. BlumDepartment of Medicine, Albert Einstein College of Medicine, and Cancer Centers and Programs, Beth Israel Medical Center and St. Luke’s Roosevelt Hospital Center, New York, New York, USA
,
Kristin N. GanjooDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA
,
Arthur StaddonMedical Oncology, Pennsylvania Oncology Hematology Associates, Philadelphia, Pennsylvania, USA
,
Martin DominkusDepartment of Orthopedic Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
,
Amy FengGlobal Biostatistics, Amgen Inc., Thousand Oaks, California, USA
,
Yi QianGlobal Health Economics, Amgen Inc., Thousand Oaks, California, USA
,
Ada BraunClinical Development, Amgen Inc., Thousand Oaks, California, USA
,
Ira JacobsClinical Development, Amgen Inc., Thousand Oaks, California, USA
,
Karen ChungGlobal Health Economics, Amgen Inc., Thousand Oaks, California, USA
&
Carolyn AtchisonGlobal Health Economics, Amgen Inc., Thousand Oaks, California, USA
 show all
Pages 1173-1179 | Received 15 Oct 2013, Accepted 26 Mar 2014, Published online: 19 May 2014

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kjetil Boye, Nina Louise Jebsen, Olga Zaikova, Heidi Knobel, Ayca M. Løndalen, Clement S. Trovik, Odd R. Monge & Kirsten Sundby Hall. (2017) Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort. Acta Oncologica 56:3, pages 479-483.
Read now
Arun S Singh, Neal S Chawla & Sant P Chawla. (2015) Giant-cell tumor of bone: treatment options and role of denosumab. Biologics: Targets and Therapy 9, pages 69-74.
Read now
Ewelina Jagiello-Wieczorek, Andrzej Pieńkowski & Piotr Rutkowski. (2015) Denosumab for treating giant cell tumor of bone. Expert Opinion on Orphan Drugs 3:10, pages 1219-1229.
Read now

Articles from other publishers (46)

Xiaoqi Tan, Yue Zhang, Daiqing Wei, Yunkang Yang & Feifan Xiang. (2023) Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis. Clinical and Experimental Medicine 23:7, pages 3053-3075.
Crossref
Bei Yuan, Songbo Han, Shaomin Yang, Lihua Zhang, Liang Jiang, Feng Wei, Huishu Yuan, Xiaoguang Liu & Zhongjun Liu. (2022) Radiologic and clinical changes after denosumab treatment for giant cell tumors of the mobile spine: a quantitative study. Insights into Imaging 13:1.
Crossref
Javier Martin-Broto, Andres Redondo, David S. Moura, Claudia Valverde, Jose Manuel Morales, Antonio Lopez-Pousa, Javier Martinez-Trufero, Antonio Gutierrez, Roberto Díaz-Beveridge, Pablo Luna, Virginia Martinez-Marin, David Marcilla, Ivan Arribas, Patricio Ledesma, Jose Antonio Lopez-Martin, Davide Di Lernia, Jorge Zamora & Nadia Hindi. (2022) A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. Nature Communications 13:1.
Crossref
Timothy A. Damron. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 27 .
Alexandra Jurczak, Lauriane Delay, Julie Barbier, Nils Simon, Emerson Krock, Katalin Sandor, Nilesh M. Agalave, Resti Rudjito, Gustaf Wigerblad, Katarzyna Rogóż, Arnaud Briat, Elisabeth Miot-Noirault, Arisai Martinez-Martinez, Dieter Brömme, Caroline Grönwall, Vivianne Malmström, Lars Klareskog, Spiro Khoury, Thierry Ferreira, Bonnie Labrum, Emmanuel Deval, Juan Miguel Jiménez-Andrade, Fabien Marchand & Camilla I. Svensson. (2022) Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3–dependent sensitization. Pain 163:8, pages 1542-1559.
Crossref
Aneta Maria Borkowska, Anna Szumera-Ciećkiewicz, Bartłomiej Szostakowski, Andrzej Pieńkowski & Piotr Lukasz Rutkowski. (2022) Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence. Cancers 14:9, pages 2290.
Crossref
Francisco de Assis Serra Baima Filho. (2022) Uso de denosumab en quiste óseo aneurismático: Revisión de la literatura. Revista Chilena de Ortopedia y Traumatología 63:01, pages e51-e54.
Crossref
Yongkun Yang, Hairong Xu, Weifeng Liu & Xiaohui Niu. (2022) Study of imaging changes following preoperative denosumab for giant cell tumor of bone. Journal of Bone Oncology 32, pages 100410.
Crossref
Ameya Bihani, Shivakumar Thiagarajan, Devendra Chaukar & AnilK D'Cruz. (2022) Giant cell tumor of hyoid bone: Diagnostic dilemma with a novel management. Journal of Cancer Research and Therapeutics 18:1, pages 282.
Crossref
Anvesh Kamble, Monalisa Hui, K. Nageshwara Rao, N. Ramakrishna, P. Chandrasekhar, Shantveer G. Uppin & G. Sadashivudu. (2021) Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study. Indian Journal of Medical and Paediatric Oncology 42:04, pages 325-332.
Crossref
Tamara Miner Haygood & Behrang Amini. (2021) Benign Osseous Tumors and Tumor-Like Conditions. Seminars in Ultrasound, CT and MRI 42:2, pages 150-163.
Crossref
David Louis Perrin, Julia D. Visgauss, David A. Wilson, Anthony M. Griffin, Albiruni R. Abdul Razak, Peter C. Ferguson & Jay S. Wunder. (2021) The role of Denosumab in joint preservation for patients with giant cell tumour of bone. The Bone & Joint Journal 103-B:1, pages 184-191.
Crossref
Saavan Patel, Ryan G. Chiu, Clayton L. Rosinski, Darius Ansari, Anisse N. Chaker, Ravi S. Nunna, Mandana Behbahani & Ankit I. Mehta. (2020) Incidence, Management, and Outcomes of Spinal Giant Cell Tumor of Bone in Adult Patients: A National Cancer Database Analysis. World Neurosurgery 144, pages e296-e305.
Crossref
Harshadkumar Dhirajlal Rajgor, Steven James, Rajesh Botchu, Melvin Grainger & Marcin Czyz. (2020) Should Denosumab or Radical Surgery Be Recommended for a Spinal Giant Cell Tumour in a Fertile Female?. Cureus.
Crossref
Emanuela Palmerini, Eric Lodewijk Staals, Louis Baxter Jones, Davide Maria Donati, Alessandra Longhi & R. Lor Randall. (2020) Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone. Current Treatment Options in Oncology 21:8.
Crossref
Josef Yayan. (2020) Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis. Cancer Control 27:3, pages 107327482093482.
Crossref
Alison M Boyce & Michael T Collins. (2020) Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation. Endocrine Reviews 41:2, pages 345-370.
Crossref
Yifei Wang & Wei Guo. 2020. Surgery of the Pelvic and Sacral Tumor. Surgery of the Pelvic and Sacral Tumor 157 163 .
Sant Chawla, Jean-Yves Blay, Piotr Rutkowski, Axel Le Cesne, Peter Reichardt, Hans Gelderblom, Robert J Grimer, Edwin Choy, Keith Skubitz, Leanne Seeger, Scott M Schuetze, Robert Henshaw, Tian Dai, Danielle Jandial & Emanuela Palmerini. (2019) Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. The Lancet Oncology 20:12, pages 1719-1729.
Crossref
Gonzalo Luengo-Alonso, Maria Mellado-Romero, Shai Shemesh, Luis Ramos-Pascua & Juan Pretell-Mazzini. (2019) Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. Archives of Orthopaedic and Trauma Surgery 139:10, pages 1339-1349.
Crossref
Patrick W. Mantyh. (2018) Mechanisms that drive bone pain across the lifespan. British Journal of Clinical Pharmacology 85:6, pages 1103-1113.
Crossref
Eiji Osaka, Yuki Okamura, Yukihiro Yoshida, Masahiko Sugitani & Yasuaki Tokuhashi. (2019) Intra-articular ectopic ossification associated with denosumab administration for giant cell tumor of bone with intra-articular pathological fracture. Journal of Orthopaedic Science 24:3, pages 558-562.
Crossref
Ourania Nicolatou-Galitis, Morten Schiødt, Rui Amaral Mendes, Carla Ripamonti, Sally Hope, Lawrence Drudge-Coates, Daniela Niepel & Tim Van den Wyngaert. (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 127:2, pages 117-135.
Crossref
Changye Zou, Tiao Lin, Bo Wang, Zhiqiang Zhao, Bin Li, Xianbiao Xie, Gang Huang, Junqiang Yin & Jingnan Shen. (2019) Managements of giant cell tumor within the distal radius: A retrospective study of 58 cases from a single center. Journal of Bone Oncology 14, pages 100211.
Crossref
Pramod Shekarappa ChinderSuraj HindiskereSrinath DoddarangappaUtkarsh Pal. (2019) Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab. Clinics in Orthopedic Surgery 11:3, pages 352.
Crossref
Arvind G. Kulkarni & Ankit Patel. (2019) Denosumab: A potential new treatment option for recurrent Aneurysmal Bone Cyst of the spine. SICOT-J 5, pages 10.
Crossref
Yongkun Yang, Yuan Li, Weifeng Liu, Hairong Xu & Xiaohui Niu. (2018) A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab. Medicine 97:46, pages e13139.
Crossref
Stephane R. Chartier, Stefanie A.T. Mitchell, Lisa A. Majuta & Patrick W. Mantyh. (2018) The Changing Sensory and Sympathetic Innervation of the Young, Adult and Aging Mouse Femur. Neuroscience 387, pages 178-190.
Crossref
R. Vellucci, R. Terenzi, J. A Kanis, H. G. Kress, R. D. Mediati, J.-Y. Reginster, R. Rizzoli & M. L. Brandi. (2018) Understanding osteoporotic pain and its pharmacological treatment. Osteoporosis International 29:7, pages 1477-1491.
Crossref
Catherine L. McCarthy, Christopher L. M. H. Gibbons, Kevin M. Bradley, A. Bass Hassan, Henk Giele & Nicholas A. Athanasou. (2017) Giant cell tumour of the distal radius/ulna: response to pre-operative treatment with short-term denosumab. Clinical Sarcoma Research 7:1.
Crossref
Andrés Redondo, Silvia Bagué, Daniel Bernabeu, Eduardo Ortiz-Cruz, Claudia Valverde, Rosa Alvarez, Javier Martinez-Trufero, Jose A. Lopez-Martin, Raquel Correa, Josefina Cruz, Antonio Lopez-Pousa, Aurelio Santos, Xavier García del Muro & Javier Martin-Broto. (2017) Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS). Cancer Chemotherapy and Pharmacology 80:6, pages 1113-1131.
Crossref
Alison M. Boyce. (2017) Denosumab: an Emerging Therapy in Pediatric Bone Disorders. Current Osteoporosis Reports 15:4, pages 283-292.
Crossref
Yifeng He, Ji Zhang & Xiaoyi Ding. (2017) Prognosis of local recurrence in giant cell tumour of bone: what can we do?. La radiologia medica 122:7, pages 505-519.
Crossref
Pui Chi Tsui, Yin-Fai Lee, Zoey Wing Yee Liu, Laura Ren Huey Ip, Wenying Piao, Alan Kwok Shing Chiang & Vivian Wai Yan Lui. (2017) An update on genomic-guided therapies for pediatric solid tumors. Future Oncology 13:15, pages 1345-1358.
Crossref
Jeannine Brant, Lisa Keller, Karen McLeod, Chao Hsing Yeh & Linda Eaton. (2017) Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology
. Clinical Journal of Oncology Nursing 21:3, pages 31-59.
Crossref
E. Palmerini, N.S. Chawla, S. Ferrari, M. Sudan, P. Picci, E. Marchesi, M. Piccinni Leopardi, I. Syed, K.K. Sankhala, P. Parthasarathy, W.E. Mendanha, M. Pierini, A. Paioli & S.P. Chawla. (2017) Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?. European Journal of Cancer 76, pages 118-124.
Crossref
Patrick Thornley, Anthony Habib, Anthony Bozzo, Nathan Evaniew & Michelle Ghert. (2017) The Role of Denosumab in the Modern Treatment of Giant Cell Tumor of Bone. JBJS Reviews 5:4.
Crossref
Timothy A. Damron. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 24 .
Sarah KellerRyota InaiShuhei SatoAkihiro TadaGerhard AdamJin YamamuraSusumu Kanazawa. (2017) Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma. American Journal of Roentgenology 208:1, pages 171-179.
Crossref
Ryan Carlisle Egbert, Ryan Folsom, Jeff Bell & Rajiv Rajani. (2017) Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis. Case Reports in Orthopedics 2017, pages 1-4.
Crossref
Panya Luksanapruksa, Jacob M. Buchowski, Weerasak Singhatanadgige, Peter C. Rose & David B. Bumpass. (2016) Management of spinal giant cell tumors. The Spine Journal 16:2, pages 259-269.
Crossref
Saranatra Waikakul, Apichat Asavamongkolkul & Rapin Phimolsarnti. (2015) Use of warm Ringer’s lactate solution in the management of locally advanced giant cell tumor of bone. International Journal of Clinical Oncology 21:1, pages 177-185.
Crossref
Keith M. Skubitz, Justin C. Peltola, Edward R. Santos & Edward Y. Cheng. (2015) Response of Aneurysmal Bone Cyst to Denosumab. Spine 40:22, pages E1201-E1204.
Crossref
Thomas Brodowicz, Margit Hemetsberger & Reinhard Windhager. (2015) Denosumab for the treatment of giant cell tumor of the bone. Future Oncology 11:13, pages 1881-1894.
Crossref
George R. MatcukJrJr, Dakshesh B. Patel, Aaron J. Schein, Eric A. White & Lawrence R. Menendez. (2015) Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy. Skeletal Radiology 44:7, pages 1027-1031.
Crossref
Natalia M. P. Fraile, Diego Toloi, Ceci O. Kurimori, Adriana R. B. Matutino, Alberto Codima, Veridiana P. Camargo, Olavo Feher & Rodrigo R. Munhoz. (2015) Successful Intravascular Correction of Intratumoral Pseudoaneurysm by Erosion of the Aorta in a Patient with Thoracic Giant Cell Tumor of Bone Responding to Denosumab. Case Reports in Oncological Medicine 2015, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.